NCT05582161: Efficacy Biomarkers of DAOIB for Dementia
- State
- Under way
- Phase
- Phase 2
- People
- 123 planned
- Started
- 3 Oct 2022
- Primary completion
- Sep 2026
- Arms
- DAOIB
- Results
- None posted
- 3 Oct 2022: Trial started
- 17 Oct 2022: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.